GOVXW (Geovax Labs) OCF Margin %: 0.00% (As of Mar. 2026)


GOVXW Geovax Labs Inc GOVXW
22 GF Score
Price $0.00
! 3 Warning Signs
View Full Analysis

What is Geovax Labs OCF Margin %?

Geovax Labs GOVXW -23.91% 22 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates GOVXW with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, Geovax Labs ranks worse than 85.51% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Geovax Labs's Cash Flow from Operations for the three months ended in Mar. 2026 was $-3.54 Mil. Geovax Labs's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Geovax Labs's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Geovax Labs's current OCF Yield % is -285.59%.

The historical rank and industry rank for Geovax Labs's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Geovax Labs was -118.88%. The lowest was -23207.32%. And the median was -234.74%.

GOVXW's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Geovax Labs OCF Margin % Related Terms

Geovax Labs OCF Margin % Historical Data

* Premium members only.

The historical data trend for Geovax Labs's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Geovax Labs OCF Margin % Chart

Geovax Labs Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,900.52 -23,207.32 0.00 -623.92 -862.76

Geovax Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -364.45 -508.69 0.00 0.00 0.00
GOVXW
22GF Score
Geovax Labs Inc GOVXW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Geovax Labs OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Geovax Labs's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-21.474/2.489
=-862.76 %

Geovax Labs's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.538/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Geovax Labs (GOVXW) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Geovax Labs and its competitors. According to the industry distribution chart, Geovax Labs ranks #820 out of 959 companies in the Biotechnology industry, placing it in the top 85.5%.
Is Geovax Labs' OCF Margin % too high?
Geovax Labs' current OCF Margin % is 0.00%. Based on the distribution chart, Geovax Labs ranks #820 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Geovax Labs has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Geovax Labs' OCF Margin % compare to BIVI and KAPA?
According to the Biotechnology industry distribution chart, Geovax Labs ranks #820 out of 959 companies for OCF Margin %. This places Geovax Labs in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Geovax Labs and its competitors. Geovax Labs's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Geovax Labs stock overvalued right now?
Geovax Labs (GOVXW) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Geovax Labs' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Geovax Labs (GOVXW), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Geovax Labs Business Description

Other Exchanges GOVX:USA
Address 1955 Lake Park Drive, Suite 300, Smyrna, GA, USA, 30080
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
22GF Score

Get the complete analysis for GOVXW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price